Key result
PET-guided biopsy prevents cardiac angiosarcoma misdiagnosis by targeting viable rather than necrotic tissue.
Why the study?
Cardiac and mediastinal angiosarcomas are rare, aggressive malignancies with nonspecific symptoms that pose major diagnostic challenges, as tumor heterogeneity and necrosis can lead to false-negative biopsies.
Case Report (n=1)
This case highlights the risk of sampling error in necrotic cardiac tumors and emphasizes the utility of PET-guided biopsy targeting viable regions for accurate diagnosis.
Raises suspicion for angiosarcoma in unexplained tamponade; leaves open optimal diagnostic strategies pending larger series.
Background and Clinical Significance: Cardiac and mediastinal angiosarcomas are rare, aggressive malignancies that often present with nonspecific symptoms and pose significant diagnostic challenges. Tumor heterogeneity and necrosis may lead to false-negative biopsy results; Case Presentation: We report a 64-year-old man who initially presented with cardiac tamponade of unclear etiology. Despite an extensive workup, the patient remained asymptomatic for five months before re-presenting with dyspnea and a large mediastinal mass compressing the right heart, along with a lytic rib lesion. Initial ultrasound-guided biopsy of the rib lesion demonstrated a benign vascular proliferation consistent with Masson tumor (intravascular papillary endothelial hyperplasia), which was discordant with aggressive imaging findings. Further evaluation with positron emission tomography–computed tomography (PET-CT) revealed peripheral metabolic activity, and cardiac magnetic resonance imaging (MRI) demonstrated a heterogeneous mass with central necrosis and peripheral enhancement. A repeat CT-guided biopsy targeting the metabolically active region confirmed angiosarcoma, with immunohistochemical staining demonstrating diffuse positivity for ERG, CD31, and CD34. The patient was treated with palliative radiation and paclitaxel-based chemotherapy but experienced rapid clinical decline and transitioned to comfort-focused care; Conclusions: This case highlights the importance of correlating imaging with pathology and emphasizes the risk of sampling error in necrotic tumors. PET-guided biopsy targeting viable tumor regions is essential in cases with discordant findings.
No takes yet. Share an insight, caveat, or question.
Obeidat et al. (2026) conducted a case report in Cardiac angiosarcoma (n=1). PET-guided biopsy was evaluated. A 64-year-old man with cardiac angiosarcoma was initially misdiagnosed with a benign Masson tumor due to sampling of necrotic tissue, highlighting the need for PET-guided biopsy of viable regions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: